EUVIMEDEUVIMED entdecken
Crossref

Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients

Atilla Çelik, Fikret Çalıkoğlu, Ahmet Akbaş, Gülçin Ercan, Ali Muhammedoğlu

Surgery Today · 2024

DOI: 10.1007/s00595-024-02837-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2024. Verfasst von Atilla Çelik und 4 weiteren Autor:innen. Beteiligte Einrichtung: İstanbul Bağcılar Training and Research Hospital, General Surgery Clinic, İstanbul, Turkey. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Neoadjuvant Therapy, Breast Neoplasms, Axilla. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Breast cancer is the most common cancer in women. Developments in breast cancer treatment have extended the life expectancy of these patients, raising the issue of morbidity of breast cancer surgery, the major cause of which is axillary dissection. The aim of the present study was to establish the safety of sentinel node biopsy (SLNB) in patients with a clinically node-negative axilla after neoadjuvant chemotherapy (NACT). METHODS: We recorded demographic data, as well as the findings of physical examination, imaging, and pathology before and after NACT. SLNB with indocyanine green + isosulfan blue and axillary dissection were performed and the surgical and pathology findings were recorded. RESULTS: A sentinel lymph node was detected in 80 of 90 patients who underwent surgery. When ≥ three sentinel lymph nodes were removed as negative in the patient group with cN0 after treatment, we evaluated the axilla as being negative with an accuracy of 100%. CONCLUSIONS: Axillary lymph-node dissection may not be necessary for patients with cNO confirmed by physical and radiological examination using positron emission tomography (PET) computed tomography (CT), and breast magnetic resonance imaging (MRI) after NACT, if ≥ three negative SLNB are removed. Further studies are needed to confirm our findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyNeoadjuvant TherapyBreast NeoplasmsAxillaLymph Node ExcisionHumansFemaleMiddle AgedAgedAdultPositron Emission Tomography Computed TomographyMagnetic Resonance ImagingLymphatic MetastasisIndocyanine Green

Stichwörter der Autor:innen

Breast cancerNeoadjuvant chemotherapySentinel lymph node biopsy

Substanzen

Indocyanine Green

Autor:innen und Institutionen

  • İstanbul Bağcılar Training and Research Hospital, General Surgery Clinic, İstanbul, Turkey.
  • General Surgery, Şanlıurfa Suruç State Hopital, Suruç, Turkey. fkrt2012@hotmail.com.
  • Faculty of Medicine, Karadeniz Technical University, General Surgery Clinic, Ortahisar, Turkey.
  • İstanbul Sultan Abdülhamid Han Training and Research Hospital, General Surgery Clinic, İstanbul, Turkey.
  • İstanbul Bağcılar Training and Research Hospital, Medical Pathology Clinic, İstanbul, Turkey.

Zitieren

APA

Çelik, A., Çalıkoğlu, F., Akbaş, A., Ercan, G., & Muhammedoğlu, A. (2024). Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients. Surgery Today. https://doi.org/10.1007/s00595-024-02837-7

Vancouver

Çelik A, Çalıkoğlu F, Akbaş A, Ercan G, Muhammedoğlu A. Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients. Surgery Today. 2024. doi:10.1007/s00595-024-02837-7

BibTeX
@article{elik2024,
  author = {Çelik, Atilla and Çalıkoğlu, Fikret and Akbaş, Ahmet and Ercan, Gülçin and Muhammedoğlu, Ali},
  title = {Efficacy of sentinel lymph-node biopsy after neoadjuvant chemotherapy in clinically axilla node-negative patients},
  journal = {Surgery Today},
  year = {2024},
  doi = {10.1007/s00595-024-02837-7}
}
Kostenlos starten →